abbott rapid diagnostics limited
abbott rapid diagnostics limited Company Information
Company Number
01716581
Next Accounts
Sep 2025
Shareholders
abbott equity holdings unlimited
Group Structure
View All
Industry
Manufacture of medical and dental instruments and supplies
Registered Address
bio-stat house, pepper road, hazel grove, stockport, SK7 5BW
Website
www.alere.comabbott rapid diagnostics limited Estimated Valuation
Pomanda estimates the enterprise value of ABBOTT RAPID DIAGNOSTICS LIMITED at £35.8m based on a Turnover of £26.5m and 1.35x industry multiple (adjusted for size and gross margin).
abbott rapid diagnostics limited Estimated Valuation
Pomanda estimates the enterprise value of ABBOTT RAPID DIAGNOSTICS LIMITED at £9.9m based on an EBITDA of £1.2m and a 8.4x industry multiple (adjusted for size and gross margin).
abbott rapid diagnostics limited Estimated Valuation
Pomanda estimates the enterprise value of ABBOTT RAPID DIAGNOSTICS LIMITED at £37.4m based on Net Assets of £16.3m and 2.3x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Abbott Rapid Diagnostics Limited Overview
Abbott Rapid Diagnostics Limited is a live company located in hazel grove, SK7 5BW with a Companies House number of 01716581. It operates in the manufacture of medical and dental instruments and supplies sector, SIC Code 32500. Founded in April 1983, it's largest shareholder is abbott equity holdings unlimited with a 100% stake. Abbott Rapid Diagnostics Limited is a mature, large sized company, Pomanda has estimated its turnover at £26.5m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Abbott Rapid Diagnostics Limited Health Check
Pomanda's financial health check has awarded Abbott Rapid Diagnostics Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
6 Weak
Size
annual sales of £26.5m, make it larger than the average company (£17.9m)
£26.5m - Abbott Rapid Diagnostics Limited
£17.9m - Industry AVG
Growth
3 year (CAGR) sales growth of -37%, show it is growing at a slower rate (6.2%)
-37% - Abbott Rapid Diagnostics Limited
6.2% - Industry AVG
Production
with a gross margin of 25.8%, this company has a higher cost of product (37.4%)
25.8% - Abbott Rapid Diagnostics Limited
37.4% - Industry AVG
Profitability
an operating margin of 3.9% make it less profitable than the average company (5.9%)
3.9% - Abbott Rapid Diagnostics Limited
5.9% - Industry AVG
Employees
with 52 employees, this is below the industry average (90)
52 - Abbott Rapid Diagnostics Limited
90 - Industry AVG
Pay Structure
on an average salary of £87.6k, the company has a higher pay structure (£49.6k)
£87.6k - Abbott Rapid Diagnostics Limited
£49.6k - Industry AVG
Efficiency
resulting in sales per employee of £508.7k, this is more efficient (£182.4k)
£508.7k - Abbott Rapid Diagnostics Limited
£182.4k - Industry AVG
Debtor Days
it gets paid by customers after 50 days, this is near the average (50 days)
50 days - Abbott Rapid Diagnostics Limited
50 days - Industry AVG
Creditor Days
its suppliers are paid after 11 days, this is quicker than average (36 days)
11 days - Abbott Rapid Diagnostics Limited
36 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Abbott Rapid Diagnostics Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 16 weeks, this is more cash available to meet short term requirements (12 weeks)
16 weeks - Abbott Rapid Diagnostics Limited
12 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 24%, this is a lower level of debt than the average (41.9%)
24% - Abbott Rapid Diagnostics Limited
41.9% - Industry AVG
ABBOTT RAPID DIAGNOSTICS LIMITED financials
Abbott Rapid Diagnostics Limited's latest turnover from December 2023 is £26.5 million and the company has net assets of £16.3 million. According to their latest financial statements, Abbott Rapid Diagnostics Limited has 52 employees and maintains cash reserves of £1.6 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 26,454,000 | 63,817,000 | 135,673,000 | 107,668,000 | 15,262,000 | 15,312,000 | 16,840,000 | 18,386,025 | 20,000,902 | 20,756,232 | 19,080,140 | 18,902,281 | 18,687,697 | 18,642,008 | 18,294,947 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 19,620,000 | 56,024,000 | 125,493,000 | 99,421,000 | 9,659,000 | 10,647,000 | 12,365,000 | 13,710,563 | 14,338,306 | 13,563,917 | 12,888,397 | 12,731,527 | 10,228,939 | 9,205,235 | 8,767,654 |
| Gross Profit | 6,834,000 | 7,793,000 | 10,180,000 | 8,247,000 | 5,603,000 | 4,665,000 | 4,475,000 | 4,675,462 | 5,662,596 | 7,192,315 | 6,191,743 | 6,170,754 | 8,458,758 | 9,436,773 | 9,527,293 |
| Admin Expenses | 5,801,000 | 6,188,000 | 6,117,000 | 4,043,000 | 5,247,000 | 4,306,000 | 3,981,000 | 7,609,230 | 5,543,432 | 5,096,179 | 6,487,011 | 6,075,050 | 6,368,067 | ||
| Operating Profit | 1,033,000 | 1,605,000 | 4,063,000 | 4,204,000 | 356,000 | 359,000 | 494,000 | -416,915 | 648,311 | 1,074,575 | 1,971,747 | 3,361,723 | 3,159,226 | ||
| Interest Payable | 3,000 | 53,017 | 90,886 | 95,430 | 120,923 | 171,075 | 261,119 | 261,120 | 286,736 | ||||||
| Interest Receivable | 759,000 | 108,000 | 18,000 | 7,000 | 25,000 | 24,000 | 30,000 | 63,754 | 165,855 | 165,855 | 74,527 | 133,648 | 184,032 | 185,444 | 184,659 |
| Pre-Tax Profit | 1,792,000 | 1,713,000 | 4,084,000 | 4,208,000 | 381,000 | 383,000 | 524,000 | 622,149 | 632,529 | -346,490 | 573,902 | 924,686 | 1,894,660 | 3,286,047 | 3,057,149 |
| Tax | -460,000 | -427,000 | -1,384,000 | -14,000 | -167,000 | -9,000 | -182,000 | -159,299 | -468,540 | -308,473 | -414,737 | -116,801 | -410,733 | -1,127,764 | -1,414,122 |
| Profit After Tax | 1,332,000 | 1,286,000 | 2,700,000 | 4,194,000 | 214,000 | 374,000 | 342,000 | 462,850 | 163,989 | -654,963 | 159,165 | 807,885 | 1,483,927 | 2,158,283 | 1,643,027 |
| Dividends Paid | 3,200,000 | 4,000,000 | |||||||||||||
| Retained Profit | 1,332,000 | 1,286,000 | 2,700,000 | 4,194,000 | 214,000 | 374,000 | 342,000 | -2,737,150 | 163,989 | -654,963 | 159,165 | 807,885 | 1,483,927 | -1,841,717 | 1,643,027 |
| Employee Costs | 4,556,000 | 4,893,000 | 4,130,000 | 2,809,000 | 3,005,000 | 2,385,000 | 2,157,000 | 1,991,438 | 2,337,349 | 3,832,298 | 3,690,727 | 4,163,301 | 3,856,008 | 3,447,242 | 3,387,032 |
| Number Of Employees | 52 | 53 | 45 | 39 | 43 | 39 | 43 | 45 | 56 | 91 | 92 | 94 | 102 | 97 | 91 |
| EBITDA* | 1,183,000 | 1,779,000 | 4,306,000 | 4,517,000 | 768,000 | 851,000 | 1,024,000 | 340,561 | 1,629,338 | 1,571,244 | 2,503,089 | 3,929,380 | 3,575,692 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 140,000 | 208,000 | 325,000 | 315,000 | 453,000 | 553,000 | 799,000 | 821,393 | 806,697 | 1,146,649 | 1,174,777 | 1,148,531 | 1,255,500 | 1,464,945 | 1,105,701 |
| Intangible Assets | 167,000 | 236,000 | 305,000 | 585,000 | 731,000 | 1,119,000 | 1,319,000 | 1,549,266 | 1,814,882 | 2,106,499 | 2,454,984 | 1,213,750 | 1,293,750 | 1,373,750 | 1,453,750 |
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | 750,000 | ||||||||||||||
| Total Fixed Assets | 307,000 | 444,000 | 630,000 | 900,000 | 1,184,000 | 1,672,000 | 2,118,000 | 3,120,659 | 2,621,579 | 3,253,148 | 3,629,761 | 2,362,281 | 2,549,250 | 2,838,695 | 2,559,451 |
| Stock & work in progress | 47,294 | 228,108 | 220,319 | 93,374 | 2,322,327 | 1,872,683 | |||||||||
| Trade Debtors | 3,676,000 | 6,760,000 | 14,200,000 | 66,369,000 | 2,248,000 | 2,350,000 | 2,705,000 | 2,601,286 | 2,846,797 | 2,759,562 | 2,336,247 | 2,472,554 | 2,695,307 | 1,901,159 | 1,977,331 |
| Group Debtors | 15,551,000 | 9,400,000 | 13,471,000 | 7,614,000 | 5,113,000 | 5,597,000 | 1,133,000 | 222,244 | 3,190,757 | 3,712,606 | 5,142,067 | 5,456,099 | 7,867,135 | 4,431,481 | 4,502,391 |
| Misc Debtors | 326,000 | 1,369,000 | 708,000 | 441,000 | 475,000 | 530,000 | 436,000 | 378,320 | 376,520 | 416,063 | 490,960 | 418,381 | 194,865 | 177,663 | 449,972 |
| Cash | 1,588,000 | 3,899,000 | 1,446,000 | 290,000 | 810,000 | 592,000 | 2,824,000 | 2,530,377 | 4,627,588 | 2,572,119 | 2,225,530 | 2,724,577 | 4,106,637 | 2,609,377 | 5,288,920 |
| misc current assets | |||||||||||||||
| total current assets | 21,141,000 | 21,428,000 | 29,825,000 | 74,714,000 | 8,646,000 | 9,069,000 | 7,098,000 | 5,732,227 | 11,041,662 | 9,507,644 | 10,422,912 | 11,291,930 | 14,957,318 | 11,442,007 | 14,091,297 |
| total assets | 21,448,000 | 21,872,000 | 30,455,000 | 75,614,000 | 9,830,000 | 10,741,000 | 9,216,000 | 8,852,886 | 13,663,241 | 12,760,792 | 14,052,673 | 13,654,211 | 17,506,568 | 14,280,702 | 16,650,748 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 606,000 | 295,000 | 701,000 | 124,000 | 203,000 | 189,000 | 188,000 | 77,322 | 180,765 | 120,239 | 45,808 | 79,587 | 89,831 | 714,895 | 686,605 |
| Group/Directors Accounts | 2,309,000 | 4,383,000 | 12,953,000 | 44,583,000 | 1,375,000 | 2,630,000 | 1,582,000 | 1,997,034 | 3,817,894 | 3,372,896 | 4,785,690 | 4,576,203 | 7,805,127 | 1,099,827 | 1,992,235 |
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | 2,231,000 | 2,246,000 | 3,144,000 | 19,860,000 | 1,443,000 | 1,591,000 | 1,646,000 | 1,424,379 | 1,753,190 | 1,554,033 | 910,013 | 1,111,562 | 2,532,636 | 2,521,435 | 2,185,647 |
| total current liabilities | 5,146,000 | 6,924,000 | 16,798,000 | 64,567,000 | 3,021,000 | 4,410,000 | 3,416,000 | 3,498,735 | 5,751,849 | 5,047,168 | 5,741,511 | 5,767,352 | 10,427,594 | 4,336,157 | 4,864,487 |
| loans | 4,349,498 | 4,349,498 | |||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | 4,349,498 | 4,349,498 | |||||||||||||
| total liabilities | 5,146,000 | 6,924,000 | 16,798,000 | 64,567,000 | 3,021,000 | 4,410,000 | 3,416,000 | 3,498,735 | 5,751,849 | 5,047,168 | 5,741,511 | 5,767,352 | 10,427,594 | 8,685,655 | 9,213,985 |
| net assets | 16,302,000 | 14,948,000 | 13,657,000 | 11,047,000 | 6,809,000 | 6,331,000 | 5,800,000 | 5,354,151 | 7,911,392 | 7,713,624 | 8,311,162 | 7,886,859 | 7,078,974 | 5,595,047 | 7,436,763 |
| total shareholders funds | 16,302,000 | 14,948,000 | 13,657,000 | 11,047,000 | 6,809,000 | 6,331,000 | 5,800,000 | 5,354,151 | 7,911,392 | 7,713,624 | 8,311,162 | 7,886,859 | 7,078,974 | 5,595,047 | 7,436,763 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 1,033,000 | 1,605,000 | 4,063,000 | 4,204,000 | 356,000 | 359,000 | 494,000 | -416,915 | 648,311 | 1,074,575 | 1,971,747 | 3,361,723 | 3,159,226 | ||
| Depreciation | 81,000 | 105,000 | 112,000 | 167,000 | 246,000 | 292,000 | 300,000 | 327,818 | 388,495 | 408,991 | 404,551 | 416,669 | 451,342 | 487,657 | 416,466 |
| Amortisation | 69,000 | 69,000 | 131,000 | 146,000 | 166,000 | 200,000 | 230,000 | 265,616 | 291,617 | 348,485 | 576,476 | 80,000 | 80,000 | 80,000 | |
| Tax | -460,000 | -427,000 | -1,384,000 | -14,000 | -167,000 | -9,000 | -182,000 | -159,299 | -468,540 | -308,473 | -414,737 | -116,801 | -410,733 | -1,127,764 | -1,414,122 |
| Stock | -47,294 | -180,814 | 7,789 | 126,945 | -2,228,953 | 449,644 | 1,872,683 | ||||||||
| Debtors | 2,024,000 | -10,850,000 | -46,045,000 | 66,588,000 | -641,000 | 4,203,000 | 322,150 | -2,462,224 | -474,157 | -1,081,043 | -377,760 | -2,410,273 | 4,247,004 | -419,391 | 6,929,694 |
| Creditors | 311,000 | -406,000 | 577,000 | -79,000 | 14,000 | 1,000 | 110,678 | -103,443 | 60,526 | 74,431 | -33,779 | -10,244 | -625,064 | 28,290 | 686,605 |
| Accruals and Deferred Income | -15,000 | -898,000 | -16,716,000 | 18,417,000 | -148,000 | -55,000 | 221,621 | -328,811 | 199,157 | 644,020 | -201,549 | -1,421,074 | 11,201 | 335,788 | 2,185,647 |
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | -1,005,000 | 10,898,000 | 32,828,000 | -43,747,000 | 1,108,000 | -3,415,000 | 852,149 | 2,012,396 | 1,349,244 | 2,306,453 | -539,558 | 3,135,441 | -3,768,555 | ||
| Investing Activities | |||||||||||||||
| capital expenditure | -242,468 | ||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | -242,468 | ||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | -2,074,000 | -8,570,000 | -31,630,000 | 43,208,000 | -1,255,000 | 1,048,000 | -415,034 | -1,820,860 | 444,998 | -1,412,794 | 209,487 | -3,228,924 | 6,705,300 | -892,408 | 1,992,235 |
| Other Short Term Loans | |||||||||||||||
| Long term loans | -4,349,498 | 4,349,498 | |||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 759,000 | 108,000 | 18,000 | 4,000 | 25,000 | 24,000 | 30,000 | 10,737 | 74,969 | 70,425 | -46,396 | -37,427 | -77,087 | -75,676 | -102,077 |
| cash flow from financing | -1,293,000 | -8,457,000 | -31,702,000 | 43,256,000 | -966,000 | 1,229,000 | -281,185 | -1,630,214 | 553,746 | -1,284,944 | 428,229 | -3,266,351 | 2,278,715 | -968,083 | 12,033,392 |
| cash and cash equivalents | |||||||||||||||
| cash | -2,311,000 | 2,453,000 | 1,156,000 | -520,000 | 218,000 | -2,232,000 | 293,623 | -2,097,211 | 2,055,469 | 346,589 | -499,047 | -1,382,060 | 1,497,260 | -2,679,543 | 5,288,920 |
| overdraft | |||||||||||||||
| change in cash | -2,311,000 | 2,453,000 | 1,156,000 | -520,000 | 218,000 | -2,232,000 | 293,623 | -2,097,211 | 2,055,469 | 346,589 | -499,047 | -1,382,060 | 1,497,260 | -2,679,543 | 5,288,920 |
abbott rapid diagnostics limited Credit Report and Business Information
Abbott Rapid Diagnostics Limited Competitor Analysis
Perform a competitor analysis for abbott rapid diagnostics limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in SK7 area or any other competitors across 12 key performance metrics.
abbott rapid diagnostics limited Ownership
ABBOTT RAPID DIAGNOSTICS LIMITED group structure
Abbott Rapid Diagnostics Limited has no subsidiary companies.
Ultimate parent company
ABBOTT LABORATORIES
#0000346
2 parents
ABBOTT RAPID DIAGNOSTICS LIMITED
01716581
abbott rapid diagnostics limited directors
Abbott Rapid Diagnostics Limited currently has 2 directors. The longest serving directors include Mr David Bond (Jun 2024) and Ms Rachael Rigby (Jun 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr David Bond | 53 years | Jun 2024 | - | Director | |
| Ms Rachael Rigby | England | 39 years | Jun 2024 | - | Director |
P&L
December 2023turnover
26.5m
-59%
operating profit
1m
-36%
gross margin
25.9%
+111.55%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
16.3m
+0.09%
total assets
21.4m
-0.02%
cash
1.6m
-0.59%
net assets
Total assets minus all liabilities
abbott rapid diagnostics limited company details
company number
01716581
Type
Private limited with Share Capital
industry
32500 - Manufacture of medical and dental instruments and supplies
incorporation date
April 1983
age
42
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
alere limited (November 2019)
inverness medical uk limited (March 2010)
See moreaccountant
-
auditor
ERNST & YOUNG
address
bio-stat house, pepper road, hazel grove, stockport, SK7 5BW
Bank
HSBC BANK PLC
Legal Advisor
BERRY SMITH LLP
abbott rapid diagnostics limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 7 charges/mortgages relating to abbott rapid diagnostics limited. Currently there are 0 open charges and 7 have been satisfied in the past.
abbott rapid diagnostics limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ABBOTT RAPID DIAGNOSTICS LIMITED. This can take several minutes, an email will notify you when this has completed.
abbott rapid diagnostics limited Companies House Filings - See Documents
| date | description | view/download |
|---|
